Peripheral T-cell lymphoma, NEC, lymph nodes mult site is a type of non-Hodgkin lymphoma characterized by the proliferation of peripheral T-cells in multiple lymph node sites. This malignancy can arise from various causes, including genetic mutations and environmental factors. Accurate coding with ICD-10 Code C84.48 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this complex condition.
ICD-10 Code C84.48 represents Peripheral T-cell lymphoma, NEC, lymph nodes mult site, a subtype of T-cell lymphoma that affects multiple lymph nodes. This code is used when documenting cases that do not fit into more specific categories of T-cell lymphoma. It is crucial for accurate clinical documentation and billing, particularly when identifying the extent of the disease and guiding treatment decisions.
Peripheral T-cell lymphoma, NEC, lymph nodes mult site is a heterogeneous group of aggressive lymphomas originating from T-cells. The exact cause remains unclear, but it is associated with immune dysregulation and environmental exposures. This condition requires prompt medical attention due to its aggressive nature and potential for systemic involvement.
ICD-10 Code C84.48 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with Peripheral T-cell lymphoma, NEC, lymph nodes mult site. This code aids in capturing the complexity of the disease in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C84.48 connects subjective patient reports and objective clinical findings to a formal diagnosis of Peripheral T-cell lymphoma, NEC, lymph nodes mult site. This linkage is vital for continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Peripheral T-cell lymphoma, NEC, lymph nodes mult site often necessitates urgent medical intervention, including hospitalization for intensive treatment. Standard approaches focus on chemotherapy and may involve targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.48 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings, ensuring accurate representation of the patient's condition.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 85025 | Complete blood count with automated differential white blood cell count. |
| 77014 | Radiologic examination, lymphatic system, for staging. |
Common Questions About Using ICD-10 Code C84.48 for Peripheral T-cell lymphoma, NEC, lymph nodes mult site
What are the common symptoms of Peripheral T-cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and itching.
How is Peripheral T-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of malignant T-cells.
What treatments are available for Peripheral T-cell lymphoma?
Treatment options often include chemotherapy, targeted therapy, and sometimes radiation therapy, depending on the stage and specific characteristics of the lymphoma.
Is Peripheral T-cell lymphoma curable?
The prognosis varies based on the subtype and stage at diagnosis. Some patients may achieve remission, while others may have a more aggressive course requiring ongoing management.
Clinical Notes
SOAP notes
DAP notes
AI medical notes